The partnership pairs Moon’s Maestro surgical robot platform with Karl Storz’s 3D visualization and instrumentation. It aims to give surgical teams a complete and more capable laparoscopic environment.
Moon Surgical said the companies hope to expand care teams’ access to innovative surgical technology. The company wants to make minimally invasive surgery more predictable and more widely accessible.
Paris-based Moon Surgical designed the FDA-cleared Maestro to provide an accessible, enhanced version of traditional laparoscopy. Maestro acts as a robotic surgical assistant to augment the precision and control of laparoscopic surgery. The small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models.
Maestro’s open architecture complements endoscopy and visualization systems, integrating with existing tools while delivering AI-powered enhancements.
Karl Storz offers a range of robotic instruments and technologies. It now has a heightened focus on these efforts, following the discontinuation of activities related to its Asensus Surgical robotic business.
Moon says its real-time, AI-native and unique intraoperative capabilities, plus workflow automation, pairs well with Karl Storz’s offerings to enable surgical teams to see clearly and operate consistently across a wider range of patients and settings.
Anne Osdoit, CEO of Moon Surgical, said:
“Scalable Surgery depends on the operating room ecosystem working together, not on any one, single device. By bringing Maestro’s capabilities together with Karl Storz, we can give surgical teams a more capable operating room and make advanced laparoscopic surgery easier to access and adopt. This collaboration helps us reach more surgeons and more sites of care, which is exactly where Scalable Surgery can do the most good for patients and hospitals.”
